Clinical Trial Update: A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial page outlining a study to compare remibrutinib with placebo in adults with generalized myasthenia gravis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Myasthenia Gravis

Drugs mentioned

• Remibrutinib (remibrutinib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Generalized Myasthenia Gravis | Phase 3 | Status: RECRUITING